Clinical Trials Logo

Clinical Trial Summary

Assessment of 21-day CGM wear period


Clinical Trial Description

This single-site study will include 10 subjects who will wear two CGMs for 21 days. On day 1, 5, 10, 15, and 21 subjects will be in-clinic for 12 hrs of testing with YSI blood glucose measurements taken every 15 minutes. ;


Study Design


NCT number NCT05460260
Study type Observational
Source WaveForm Technologies Inc.
Contact
Status Completed
Phase
Start date September 12, 2020
Completion date November 15, 2020